Fig. 5

Establishment of an 11-DEIRG-based OS signature and a 9-DEIRG-based PFS signature. (a, f) Time-dependent ROC curves of the OS and PFS signatures at 1, 2, and 3 years. (b, g) Kaplan–Meier survival curves showing the differences in OS and PFS between low-risk and high-risk patients. (c, h) Differential gene expression between the high-risk and low-risk groups in the OS and PFS signatures. (d, i) OS and PFS scatter plots for sarcoma patients. (e, j) Risk score distribution of patients with the OS and PFS signatures. DEIRGs: Differentially expressed immune-related genes; OS Overall survival, PFS Progression-free survival, ROC Receiver operating characteristic